Second-line afatinib administration in an elderly patient with squamous cell carcinoma

Second-line afatinib administration in an elderly patient with squamous cell carcinoma

Wolfgang Hohenforst-Schmidt,1 Paul Zarogoulidis,2 Michael Steinheimer,1 Naim Benhassen,3 Chrysanthi Sardeli,4 Nikos Stalikas,2 Melpomeni Toitou,2 Haidong Huang5 1Sana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, “Hof” Clinics, University...

Full description

Bibliographic Details
Main Authors: Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Sardeli C, Stalikas N, Toitou M, Huang H
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Therapeutics and Clinical Risk Management
Subjects:
lung cancer
egfr
afatinib
Online Access:https://www.dovepress.com/second-line-afatinib-administration-in-an-elderly-patient-with-squamou-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/second-line-afatinib-administration-in-an-elderly-patient-with-squamou-peer-reviewed-article-TCRM

Similar Items